Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Membrane (M) and Spike (S) Proteins Antagonize Host Type I Interferon Response
Qi Zhang, Zhiqiang Chen, Chenxiao Huang, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Innate immune evasion strategies of SARS-CoV-2
Judith M. Minkoff, Benjamin R. tenOever
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 157
Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy
Mahdi Eskandarian Boroujeni, Agata Sekrecka, Aleksandra Antonczyk, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
Toward a pan-SARS-CoV-2 vaccine targeting conserved epitopes on spike and non-spike proteins for potent, broad and durable immune responses
Chang Yi Wang, Wen‐Jiun Peng, Be-Sheng Kuo, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 4, pp. e1010870-e1010870
Open Access | Times Cited: 24
Transcription Kinetics in the Coronavirus Life Cycle
Katarzyna Grelewska‐Nowotko, Ahmed Eısa Elhag, Tomasz W. Turowski
Wiley Interdisciplinary Reviews - RNA (2025) Vol. 16, Iss. 1
Open Access
SARS-CoV-2 spike protein in infectivity
Alaa Muayad Altaie, Rania Hamdy, Mohamed I. Husseiny, et al.
Elsevier eBooks (2025), pp. 21-56
Closed Access
Dissecting the COVID‐19 Immune Response: Unraveling the Pathways of Innate Sensing and Response to SARS‐CoV‐2 Structural Proteins
María Guadalupe Vizoso-Pinto, Leonardo de Paula Pereira, Ana Luiza Pessoa de Mendonça Angelo, et al.
Journal of Molecular Recognition (2025) Vol. 38, Iss. 2
Closed Access
Anti-interferon armamentarium of human coronaviruses
Oyahida Khatun, Sumandeep Kaur, Shashank Tripathi
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Cellular signalling by SARS-CoV-2 spike protein
Nicholas P. Gracie, Lachlan Yuek Shun Lai, Timothy P. Newsome
Microbiology Australia (2024) Vol. 45, Iss. 1, pp. 13-17
Open Access | Times Cited: 3
SARS-CoV-2 ORF6 protein targets TRIM25 for proteasomal degradation to diminish K63-linked RIG-I ubiquitination and type-I interferon induction
Oyahida Khatun, Mansi Sharma, Rohan Narayan, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 12
Open Access | Times Cited: 8
The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection
Mathias Martins, Mohammed Nooruzzaman, Jessie Lee Cunningham, et al.
Journal of Virology (2024) Vol. 98, Iss. 3
Open Access | Times Cited: 2
TRIM7 ubiquitinates SARS-CoV-2 membrane protein to limit apoptosis and viral replication
María González-Orozco, Tseng Hsiang-Chi, Adam Hage, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
CRISPR‐Cas13d effectively targets SARS‐CoV‐2 variants, including Delta and Omicron, and inhibits viral infection
Zongzhi Liu, Xiang Gao, Chuanwen Kan, et al.
MedComm (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 7
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
Denisa Bojková, Marek Widera, Sandra Ciesek, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 11
The Evolutionary Dance between Innate Host Antiviral Pathways and SARS-CoV-2
Saba R. Aliyari, Natalie Quanquin, Olivier Pernet, et al.
Pathogens (2022) Vol. 11, Iss. 5, pp. 538-538
Open Access | Times Cited: 11
Delineating the SARS-CoV-2 Induced Interplay between the Host Immune System and the DNA Damage Response Network
Christina Papanikolaou, Vasiliki Rapti, Dimitris Stellas, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1764-1764
Open Access | Times Cited: 10
Zebrafish models of COVID-19
Sylwia D. Tyrkalska, Sergio Candel, Annamaria Pedoto, et al.
FEMS Microbiology Reviews (2022) Vol. 47, Iss. 1
Open Access | Times Cited: 10
Host factors of SARS-CoV-2 in infection, pathogenesis, and long-term effects
Yu Zhang, Shihan Chen, Yan Tian, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1
Implications of SARS‐CoV‐2 Immunity in the Context of the Pathogenesis of COVID‐19, Immune Evasion of the Virus, and the Effectiveness of Vaccination
Hikmet Akkız
(2024)
Open Access | Times Cited: 1
Improved understanding of biorisk for research involving microbial modification using annotated sequences of concern
Gene D. Godbold, F. Curtis Hewitt, Anthony D. Kappell, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 4
SARS-COV-2 protein NSP9 promotes cytokine production by targeting TBK1
Yihua Zhang, Bowen Xin, Yinan Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Immune-Related Protein Interaction Network in Severe COVID-19 Patients toward the Identification of Key Proteins and Drug Repurposing
Pakorn Sagulkoo, Apichat Suratanee, Kitiporn Plaimas
Biomolecules (2022) Vol. 12, Iss. 5, pp. 690-690
Open Access | Times Cited: 6
Mechanism of COVID-19-Related Proteins in Spinal Tuberculosis: Immune Dysregulation
Liyi Chen, Chong Liu, Tuo Liang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
SARS-CoV-2 RBD protein enhances the oncolytic activity of the vesicular stomatitis virus
Almohanad A. Alkayyal, Reham Ajina, Marco Cacciabue, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Bridging the Gap: Can COVID-19 Research Help Combat African Swine Fever?
Danaya Pakotiprapha, Sakonwan Kuhaudomlarp, Ruchanok Tinikul, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1925-1925
Open Access | Times Cited: 2
SARS-Cov-2 small viral RNA suppresses gene expression via complementary binding to mRNA 3' UTR.
Haley A Delcher, Jeffrey D DeMeis, Nicole Ghobar, et al.
PubMed (2024) Vol. 2024
Closed Access
Page 1 - Next Page

Scroll to top